eCite Digital Repository

Cross-sectional study exploring barriers to adverse drug reactions reporting in community pharmacy settings in Dhaka, Bangladesh


Amin, MN and Khan, TM and Dewan, SMR and Islam, MS and Moghal, MR and Ming, LC, Cross-sectional study exploring barriers to adverse drug reactions reporting in community pharmacy settings in Dhaka, Bangladesh, BMJ Open, 6, (8) Article e010912. ISSN 2044-6055 (2016) [Refereed Article]


Copyright Statement

Copyright 2016 The Author(s) Licensed under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)

DOI: doi:10.1136/bmjopen-2015-010912


Objectives: To assess community pharmacists'/pharmacy technicians' knowledge and perceptions about adverse drug reactions (ADRs) and barriers towards the reporting of such reactions in Dhaka, Bangladesh.

Method: A cross-sectional study was planned to approach potential respondents for the study. A self-administered questionnaire was delivered to community pharmacists/pharmacy technicians (n = 292) practising in Dhaka, Bangladesh.

Results: The overall response to the survey was 69.5% (n = 203). The majority of the sample was comprised of pharmacy technicians (152, 74.9%) who possessed a diploma in pharmacy, followed by pharmacists (37, 18.2%) and others (12, 5.9%). Overall, 72 (35.5%) of the respondents disclosed that they had experienced an ADR at their pharmacy, yet more than half (105, 51.7%) were not familiar with the existence of an ADR reporting body in Bangladesh. Exploring the barriers to the reporting of ADRs, it was revealed that the top four barriers to ADR reporting were ‘I do not know how to report (Relative Importance Index (RII) = 0.998)’, ‘reporting forms are not available (0.996)’, ‘I am not motivated to report (0.997)’ and ‘Unavailability of professional environment to discuss about ADR (RII = 0.939)’. In addition to these, a majority (141, 69.46%) were not confident about the classification of ADRs (RII = 0.889) and were afraid of legal liabilities associated with reporting ADRs (RII = 0.806). Moreover, a lack of knowledge about pharmacotherapy and the detection of ADRs was another major factor hindering their reporting (RII = 0.731).

Conclusions: The Directorate of Drug Administration in Bangladesh needs to consider the results of this study to help it improve and simplify ADR reporting in Bangladeshi community pharmacy settings.

Item Details

Item Type:Refereed Article
Research Division:Biomedical and Clinical Sciences
Research Group:Pharmacology and pharmaceutical sciences
Research Field:Clinical pharmacy and pharmacy practice
Objective Division:Expanding Knowledge
Objective Group:Expanding knowledge
Objective Field:Expanding knowledge in the health sciences
UTAS Author:Ming, LC (Dr Long Ming)
ID Code:114864
Year Published:2016
Web of Science® Times Cited:8
Deposited By:Pharmacy
Deposited On:2017-03-01
Last Modified:2017-11-02
Downloads:153 View Download Statistics

Repository Staff Only: item control page